ALPS Medical Breakthroughs ETF - USD Stock

ETF

SBIO

US00162Q5936

Delayed Nyse 12:57:58 2024-04-25 pm EDT 5-day change 1st Jan Change
31.42 USD -1.38% Intraday chart for ALPS Medical Breakthroughs ETF - USD -2.88% -4.62%
Current month-10.88%
1 month-8.76%
Dynamic Chart

Investment objective

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the S-Network Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
Name
Price
Change
5d. change
1st Jan change
Weight
25.7 USD -4.28%+0.51%+12.08%-.--%
39.95 USD +1.32%-0.15%+159.75%-.--%
8.58 USD -3.81%-6.33%-23.19%-.--%
32.54 USD -4.15%-2.72%-20.94%-.--%
60.3 USD -0.95%-3.41%-3.98%4.03%
41.9 USD -0.24%+0.72%-1.18%4.03%
16.59 USD -0.90%-3.49%-47.01%3.42%
35.59 USD -1.86%-3.34%+24.09%3.18%
24.65 USD +1.57%+2.67%-11.14%3.17%
71.17 USD -2.61%+2.09%-10.58%2.52%
See all (93)
In partnership with
TrackInsight
Date Price Change Volume
24-04-25 31.42 -1.38% 9 438
24-04-24 31.86 -1.16% 22,859
24-04-23 32.24 +1.03% 8,290
24-04-22 31.91 +0.99% 6,335
24-04-19 31.59 -0.67% 49,312

Delayed Quote Nyse

Last update April 24, 2024 at 04:10 pm EDT

More quotes

ETF Ratings

Description

US00162Q5936
Total Expense Ratio 0.50%
Asset Class
Sector
Size
Currency
Provider
Underlying S-Network Medical Breakthroughs Index NTR - USD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2014-12-29
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-03-27 )

AuM (EUR) 107 M€
AuM 1M 113 M€
AuM 3 months 92 M€
AuM 6 months 84 M€
AuM 12 months 87 M€
  1. Stock Market
  2. ETF
  3. SBIO ETF